Inhibition of Both Jak2 and STAT5 Enhances Toxicity to Myeloproliferative Cells.

被引：0
|
作者：
Bar-Natan, Michal [1 ]
Nelson, Erik A. [1 ]
Walker, Sarah R. [1 ]
Barrett, Rosemary [1 ]
Frank, David A. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：756 / 756
页数：1
相关论文
共 50 条
  • [21] EPO prevents apoptosis via JAK2/STAT5 in experimental epilepsy
    Li Jie
    Ma Baoxin
    Li Qun
    Wu Suisheng
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C85 - C85
  • [22] ACTIVATED STAT5 AS NOVEL STEM TARGET IN JAK2 V617F POSITIVE MYELOPROLIFERATIVE NEOPLASMS (MPN)
    Hadzijusufovic, E.
    Keller, A.
    Schur, F.
    Cerny-Reiterer, S.
    Hoermann, G.
    Mayerhofer, M.
    Boudot, C.
    Gouilleux, F.
    Muellauer, L.
    Moriggl, R.
    Valent, P.
    HAEMATOLOGICA, 2015, 100 : 524 - 525
  • [23] Multitarget Antileukemic Effects of Metformin in Myeloproliferative Neoplasm Cells: Inhibition of JAK2/STAT Signaling and Mitochondrial Activity
    Machado-Neto, Joao Agostinho
    Fenerich, Bruna Alves
    Scopim-Ribeiro, Renata
    Dechandt, Carlos Roberto Porto
    Alves, Ana Paula Nunes Rodrigues
    Fernandes, Jaqueline Cristina
    Scheucher, Priscila Santos
    Simoes, Belinda Pinto
    Alberici, Luciane Carla
    Pontes, Lorena Lobo de Figueiredo
    Rego, Eduardo Magalhaes
    Traina, Fabiola
    BLOOD, 2016, 128 (22)
  • [24] STAT5 Activation Is Critical for the Transformation Mediated by Myeloproliferative Disorder-associated JAK2 V617F Mutant
    Funakoshi-Tago, Megumi
    Tago, Kenji
    Abe, Miyuki
    Sonoda, Yoshiko
    Kasahara, Tadashi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (08) : 5296 - 5307
  • [25] Expression of phosphorylated STAT5 in the putative stem cell population of JAK2 V617F transformed myeloproliferative neoplasms
    Hadzijusufovic, E.
    Keller, A.
    Schur, F.
    Cerny-Reiterer, S.
    Sadovnik, I
    Pecnard, E.
    Gouilleux, F.
    Valent, P.
    ONKOLOGIE, 2013, 36 : 288 - 288
  • [26] Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes
    McWhinney, CD
    Dostal, D
    Baker, K
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (04) : 751 - 761
  • [27] Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2
    Schwaller, J
    Parganas, E
    Wang, DM
    Cain, D
    Aster, JC
    Williams, IR
    Lee, CK
    Gerthner, R
    Kitamura, T
    Frantsve, J
    Anastasiadou, E
    Loh, ML
    Levy, DE
    Ihle, JN
    Gilliland, DG
    MOLECULAR CELL, 2000, 6 (03) : 693 - 704
  • [28] The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma
    Keller, Alexandra
    Wingelhofer, Bettina
    Peter, Barbara
    Bauer, Karin
    Berger, Daniela
    Gamperl, Susanne
    Reifinger, Martin
    Cerny-Reiterer, Sabine
    Moriggl, Richard
    Willmann, Michael
    Valent, Peter
    Hadzijusufovic, Emir
    VETERINARY AND COMPARATIVE ONCOLOGY, 2018, 16 (01) : 55 - 68
  • [29] Persistent Stat5 activation supports functional erythropoiesis in the absence of Jak2 and EPOR
    Grebien, F.
    Kerenyi, M. A.
    Kovacic, B.
    Kolbe, T.
    Klingmuller, U.
    Mueller, M.
    Beug, H.
    Moriggl, R.
    Mullner, E. W.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 106 - 106
  • [30] JAK2/STAT5 Pathway Mediates Prolactin-Induced Apoptosis of Lactotropes
    de Dios, Nataly
    Orrillo, Santiago
    Irizarri, Martin
    Susana Theas, Maria
    Boutillon, Florence
    Candolfi, Marianela
    Seilicovich, Adriana
    Goffin, Vincent
    Pisera, Daniel
    Ferraris, Jimena
    NEUROENDOCRINOLOGY, 2019, 108 (02) : 84 - 97
12345